Insights into Digital Therapeutics Space and Associated Evidence Thresholds

Diana Brixner, PhD, FAMCP, of the University of Utah opens a discussion surrounding digital therapeutics.

Now Viewing

EP: 1.Insights into Digital Therapeutics Space and Associated Evidence Thresholds

EP: 2.Evidence Thresholds for Prescription vs Non-Prescription Digital Therapeutics

EP: 3.Industry Collaboration in Shaping Digital Therapeutics Standards

EP: 4.Payer Challenges in Evaluating Digital Therapeutics

EP: 5.Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics

EP: 6.Developing Reimbursement Models for Digital Therapeutics

EP: 7.Adoption Lessons For Payers

EP: 8.Gaps in Evidence Generation for Digital Therapeutics

EP: 9.Overcoming Implementation Barriers for Digital Therapeutics Adoption

Recent Videos

Related Content

---

Value-Based Decision-Making in Metastatic Breast Cancer

Ian E. Krop, MD, PhD;Debra Patt, MD, PhD, MBA

September 12th 2025

Article

Read More

Related Content

---

Value-Based Decision-Making in Metastatic Breast Cancer

Ian E. Krop, MD, PhD;Debra Patt, MD, PhD, MBA

September 12th 2025

Article

Read More